View of RESULT OF PEMBROLIZUMAB PLUS CHEMOTHERAPY IN THE FIRST-LINE THERAPY FOR DISTANT METASTATIC NON-SMALL-CELL LUNG CANCER WITH PD-L1 ≥1%, EGFR(-), ALK(-) AND ROS1(-)

Return to Article Details RESULT OF PEMBROLIZUMAB PLUS CHEMOTHERAPY IN THE FIRST-LINE THERAPY FOR DISTANT METASTATIC NON-SMALL-CELL LUNG CANCER WITH PD-L1 ≥1%, EGFR(-), ALK(-) AND ROS1(-) Download Download PDF